+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Veterinary Molecular Diagnostics Market Size, Share, and Trends - Forecast to 2036

  • PDF Icon

    Report

  • 250 Pages
  • October 2026
  • Region: Global
  • Meticulous Market Research Pvt. Ltd.
  • ID: 6290686
The global veterinary molecular diagnostics market was valued at USD 812.6 million in 2025. The market is estimated at USD 886.4 million in 2026 and is projected to reach USD 2.13 billion by 2036, at a CAGR of 9.2% during the forecast period 2026-2036. This report provides a detailed assessment of the market, covering animal disease trends, PCR, sequencing, microarray, and point-of-care technologies, molecular versus immunoassay testing, regulation, cost per test, the supplier landscape, and future growth opportunities.

The market covers the kits, reagents, instruments, and software that laboratories and clinics use to read pathogen and animal DNA and RNA for disease diagnosis, surveillance, and genetic testing. Products in scope include PCR assays in real-time, digital, and conventional formats, multiplex syndromic panels, extraction kits and automated extraction systems, thermal cyclers and point-of-care molecular analyzers, sequencing for pathogen characterization and genotyping, genotyping microarrays, and laboratory and data analysis software. ELISA and other immunoassays, rapid antigen and antibody tests, clinical chemistry, hematology, imaging, food safety testing of animal products, environmental DNA monitoring of wildlife, and human molecular diagnostics are excluded.

Between January 2022 and June 2026, African swine fever (ASF) was reported by 76 countries and territories, according to the World Organisation for Animal Health (WOAH), with 14,951 outbreaks in domestic pigs, 2.74 million animals lost, and 34,388 outbreaks in wild boar, and Finland recorded its first case in wild boar in July 2026. In the U.K., Defra had confirmed 270 bluetongue virus serotype 3 (BTV-3) cases on farms in England and Wales by August 7, 2026, within a month of the season's first case on July 10, after 348 cases in Great Britain in 2025-2026. On the companion animal side, IDEXX Laboratories reported second-quarter 2026 revenue of USD 1.21 billion, up 10%, with Companion Animal Group Diagnostics recurring revenue up 11%.

Market Dynamics

Outbreaks of transboundary and zoonotic diseases are a major driver of the veterinary molecular diagnostics market, because governments and producers rely on sensitive PCR testing to confirm cases, set restriction zones, and clear animals for movement and trade. With no widely available ASF vaccine in most countries, control depends on early detection and culling, and disease-free countries keep testing to catch any introduction. H5N1 avian influenza has reached U.S. dairy cattle since 2024, and the USDA Animal and Plant Health Inspection Service (APHIS) continues the National Milk Testing Strategy alongside an April 2024 Federal Order requiring tests of lactating dairy cattle before interstate movement. Rising pet ownership and spending on care, broader reference laboratory PCR panels for respiratory, gastrointestinal, and vector-borne disease in dogs and cats, and genomic selection, parentage, and trait testing in cattle, swine, and poultry add further demand.

Molecular tests cost more than rapid antigen and antibody tests and need specialized instruments and staff, so low-margin livestock producers often test only in outbreaks or for high-value animals. Many countries in Africa, Asia, and Latin America lack veterinary laboratory capacity outside major cities. Assays for notifiable diseases often need national approval or validation, which adds time and cost despite WOAH harmonization, a positive PCR result does not always mean active infection, and livestock testing volumes rise sharply in outbreaks and fall afterward, which complicates capacity and inventory planning.

Point-of-care PCR and isothermal systems that give results during the clinic visit or pen-side on farms are a key opportunity, as is whole-genome sequencing for strain identification, outbreak tracing, new variants, and antimicrobial resistance genes, as seen in sequencing of H5N1 viruses from cattle and poultry. One Health surveillance programs and new veterinary laboratories in China, India, Brazil, and Southeast Asia offer further openings. Key trends include multiplex syndromic panels, consolidation of diagnostics and genetics, and closer links between testing, practice management software, and surveillance platforms.

Segment Analysis

The report analyzes the market by product, technology, application, animal type, end user, and geography, helping stakeholders identify the most attractive growth areas.

By product, the veterinary molecular diagnostics market is segmented into kits & reagents, instruments, and software. Kits & reagents span assay, extraction, and sequencing kits and other reagents, and instruments span PCR, sequencing, and extraction systems and point-of-care analyzers. Kits & reagents are expected to hold the largest share in 2026, since PCR kits and extraction reagents are used up in every test, surveillance of ASF, avian influenza, and bluetongue requires very large test volumes, and companion animal reference laboratory panels keep expanding. Software is projected to record the highest CAGR, as testing is linked with laboratory information systems, practice management tools, and surveillance platforms and sequencing output needs bioinformatics analysis. Instruments should grow steadily on laboratory automation and point-of-care analyzers.

By technology, the veterinary molecular diagnostics market is segmented into PCR, DNA sequencing, microarray, and other technologies such as LAMP and other isothermal methods. PCR, covering real-time, digital, and conventional PCR, leads in 2026, as real-time PCR is the standard method for confirming viral and bacterial pathogens, WOAH diagnostic standards recommend it for many notifiable diseases, and it underpins national ASF, avian influenza, and bluetongue programs and companion animal panels. DNA sequencing, including next-generation and Sanger sequencing, is set to grow the fastest, supported by lower sequencing costs, wider use of whole-genome sequencing for pathogen typing, outbreak tracing, and resistance detection, and sequencing-based genotyping in animal genetics. Microarrays stay relevant for livestock genotyping.

By application, the veterinary molecular diagnostics market is segmented into infectious diseases (viral, bacterial, parasitic, and fungal), genetics (inherited disease, genomic selection & trait, and parentage & identity testing), metabolic diseases, and other applications such as oncology and pharmacogenetics. Infectious diseases hold the largest share in 2026, reflecting the central role of PCR in diagnosing and monitoring infections in livestock and pets, the impact of ASF, avian influenza, and bluetongue, and the routine use of infectious disease panels in clinics. Genetics is projected to record the highest CAGR, driven by genomic selection by cattle, pig, and poultry breeders, DNA tests for inherited diseases and traits in dogs and cats, and animal health company investment in genomics, including Zoetis' agreement to acquire Neogen's genomics business.

By animal type, the veterinary molecular diagnostics market is segmented into companion animals (dogs, cats, horses, and other companion animals) and livestock animals (cattle, swine, poultry, small ruminants, and other livestock animals). Companion animals are expected to hold the largest share in 2026, supported by high spending on pet care, routine ordering of PCR panels for dogs and cats from reference laboratories, and strong growth in companion animal diagnostics, as IDEXX's results show. Livestock animals are projected to grow the fastest, as ASF, avian influenza, and bluetongue spread, national surveillance and pre-movement testing programs expand, and breeders adopt genomic testing. Cattle are expected to be a major part of livestock demand, given H5N1 testing in dairy herds, bluetongue surveillance, and genomic selection.

By end user, the veterinary molecular diagnostics market is segmented into veterinary reference & diagnostic laboratories, veterinary hospitals & clinics, and research institutes. Reference & diagnostic laboratories, including commercial reference laboratories and national, state, and university laboratories, hold the largest share in 2026, as molecular testing is concentrated where the instruments and expertise exist, IDEXX and Antech Diagnostics run large reference networks, and government laboratories test for notifiable diseases. Veterinary hospitals & clinics are set to grow the fastest, supported by point-of-care molecular analyzers, veterinarians' wish for results during the visit, and large hospital groups building in-house diagnostics.

Regional Analysis

The report covers North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, spanning 20 countries and four rest-of-region groups. The regional analysis considers livestock populations, disease outbreaks, pet care spending, laboratory networks, and surveillance programs.

North America is expected to hold the largest share of the global veterinary molecular diagnostics market in 2026, supported by high companion animal healthcare spending, the reference laboratory networks of IDEXX and Antech Diagnostics, home-based suppliers including Zoetis, Neogen, and Thermo Fisher Scientific, and broad livestock disease surveillance, including H5N1 milk and pre-movement testing. The U.S. is also the biggest single market for genomic testing of livestock.

Asia-Pacific is projected to grow at the highest CAGR, driven by large pig and poultry populations, ASF and avian influenza in China, Vietnam, and other countries, new veterinary diagnostic laboratories, and fast-rising pet ownership and care spending in China, Japan, South Korea, and India. China, the world's largest pig producer, is seeing strong PCR demand from ASF control and the growth of large commercial farms. Europe holds a significant share, supported by ASF in wild boar and domestic pigs, bluetongue and avian influenza outbreaks, strong national laboratory systems, and specialist suppliers based in the region, including Germany's Indical Bioscience and France's Innovative Diagnostics. Latin America, led by the large livestock industries of Brazil, Argentina, and Mexico, and the Middle East & Africa, supported by investment in veterinary services and disease control, account for smaller shares.

Competitive Landscape

The report provides a detailed review of the competitive landscape, covering key growth strategies, competitive benchmarking, the competitive dashboard, and market share/rank analysis by key player for 2025. Company profiles include business and financial overviews, veterinary molecular diagnostics portfolios, product portfolios, strategic developments, and SWOT analyses.

Animal health and diagnostics leaders such as IDEXX, Antech Diagnostics, and Zoetis compete in the moderately consolidated veterinary molecular diagnostics market alongside life science suppliers including QIAGEN, Bio-Rad Laboratories, and Thermo Fisher Scientific and specialists such as Indical Bioscience, Innovative Diagnostics, and Neogen. Competition rests on assay menu breadth, approvals and validations, sensitivity and specificity, throughput and automation, turnaround time, point-of-care capability, and ties with reference laboratories and national veterinary authorities. Leading players are widening assay menus, building multiplex panels and point-of-care platforms, investing in automation and sequencing, and connecting testing with software. Notable developments include Neogen's March 2026 agreement to sell its GeneSeek genomics business, including the Igenity and GGP portfolios, to Zoetis, Mars' combination of Heska with Antech Diagnostics, and continued growth in IDEXX reference laboratory revenue.

Key companies profiled in the report include IDEXX Laboratories, Inc. (U.S.), Antech Diagnostics, Inc. (Mars, Incorporated) (U.S.), Zoetis Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Netherlands), Bio-Rad Laboratories, Inc. (U.S.), Neogen Corporation (U.S.), Indical Bioscience GmbH (Germany), and Innovative Diagnostics SAS (France).

How This Report Helps

  • Provides reliable market size estimates and long-term forecasts for the global veterinary molecular diagnostics market.
  • Explains how ASF, avian influenza, bluetongue, and companion animal care are shaping demand for molecular testing.
  • Assesses the impact of testing costs, limited laboratory capacity, assay approval rules, and outbreak-driven demand swings.
  • Identifies high-growth opportunities across product, technology, application, animal type, end user, and region.
  • Tracks point-of-care PCR, multiplex panels, whole-genome sequencing, and livestock and pet genetic testing.
  • Benchmarks leading companies by assay menu, platforms, laboratory networks, and strategic developments.
  • Supports product planning, partnering, and market entry decisions for diagnostics companies and investors.

Key Questions Answered

  • How big is the global veterinary molecular diagnostics market today, and how will it grow through 2036?
  • What are the main drivers, restraints, opportunities, challenges, and trends shaping the market?
  • How are ASF, H5N1 in dairy cattle, and bluetongue outbreaks affecting PCR testing volumes?
  • How fast will point-of-care molecular testing move from reference laboratories into clinics and farms?
  • Which product, technology, application, animal type, and end-user segments will grow the fastest?
  • What do recent deals in animal diagnostics and genomics mean for competition?
  • Which regions and countries offer the most attractive business opportunities?
  • Who are the leading companies in the market, and how do they compare on assay menus and platforms?

Table of Contents

1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency and Limitations
1.3.1. Currency
1.3.2. Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Data Collection & Validation Process
2.2.1. Secondary Research
2.2.2. Primary Research & Validation
2.2.2.1. Primary Interviews with Industry Experts
2.2.2.2. Country-/Region-Level Analysis
2.3. Market Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
2.3.3. Forecast Methodology
2.4. Data Triangulation
2.5. Assumptions
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Rising Incidence of Transboundary and Zoonotic Animal Diseases
4.2.1.2. Growing Companion Animal Population and Pet Healthcare Spending
4.2.1.3. Expansion of Reference Laboratory Molecular Testing Panels
4.2.1.4. Increasing Adoption of Genomic Testing in Livestock
4.2.2. Restraints
4.2.2.1. High Cost of Molecular Testing
4.2.2.2. Limited Laboratory Infrastructure in Developing Countries
4.2.3. Opportunities
4.2.3.1. Point-of-Care Molecular Testing in Veterinary Clinics
4.2.3.2. Sequencing for Pathogen Characterization and Genomic Surveillance
4.2.3.3. One Health and Zoonotic Disease Surveillance Programs
4.2.3.4. Expansion of Veterinary Laboratory Infrastructure in Emerging Economies
4.2.4. Challenges
4.2.4.1. Regulatory Approval and Validation of Veterinary Assays
4.2.4.2. Interpretation of PCR Results and Outbreak-Driven Demand Volatility
4.2.5. Trends
4.2.5.1. Shift Toward Multiplex Syndromic Panels
4.2.5.2. Consolidation and Integration of Diagnostics and Genetics
4.2.5.3. Integration of Molecular Diagnostics with Data and Software Platforms
4.3. Technology Landscape
4.3.1. Real-Time and Digital PCR
4.3.2. Multiplex Syndromic Panels
4.3.3. Point-of-Care and Isothermal Molecular Platforms
4.3.4. Next-Generation Sequencing and Whole-Genome Sequencing
4.3.5. Genotyping Microarrays
4.3.6. Laboratory Automation and Informatics
4.4. Molecular vs. Immunoassay-Based Veterinary Diagnostics: Comparative Analysis
4.5. Animal Disease Landscape
4.5.1. African Swine Fever
4.5.2. Highly Pathogenic Avian Influenza (Including H5N1 in Dairy Cattle)
4.5.3. Bluetongue and Other Vector-Borne Diseases
4.5.4. Foot-and-Mouth Disease and Other Transboundary Diseases
4.5.5. Companion Animal Infectious Diseases
4.6. Value Chain Analysis
4.6.1. Assay and Instrument Development
4.6.2. Manufacturing and Validation
4.6.3. Distribution
4.6.4. Laboratory and Point-of-Care Testing
4.6.5. Data, Reporting, and Surveillance
4.7. Regulatory Landscape
4.7.1. WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals
4.7.2. North America (USDA CVB, NAHLN)
4.7.3. Europe (EU Animal Health Law, National Reference Laboratories)
4.7.4. Asia-Pacific
4.8. Porter’s Five Forces Analysis
4.9. Pricing and Cost-per-Test Analysis
5. Veterinary Molecular Diagnostics Market, by Product
5.1. Introduction
5.2. Kits & Reagents
5.2.1. PCR Assay Kits
5.2.2. Nucleic Acid Extraction Kits
5.2.3. Sequencing Kits & Reagents
5.2.4. Other Reagents
5.3. Instruments
5.3.1. PCR Systems
5.3.2. Sequencing Systems
5.3.3. Nucleic Acid Extraction Systems
5.3.4. Point-of-Care Molecular Analyzers
5.4. Software
6. Veterinary Molecular Diagnostics Market, by Technology
6.1. Introduction
6.2. Polymerase Chain Reaction (PCR)
6.2.1. Real-Time PCR
6.2.2. Digital PCR
6.2.3. Conventional PCR
6.3. DNA Sequencing
6.3.1. Next-Generation Sequencing
6.3.2. Sanger Sequencing
6.4. Microarray
6.5. Other Technologies
7. Veterinary Molecular Diagnostics Market, by Application
7.1. Introduction
7.2. Infectious Diseases
7.2.1. Viral Diseases
7.2.2. Bacterial Diseases
7.2.3. Parasitic Diseases
7.2.4. Fungal Diseases
7.3. Genetics
7.3.1. Genetic Disease Testing
7.3.2. Genomic Selection & Trait Testing
7.3.3. Parentage & Identity Testing
7.4. Metabolic Diseases
7.5. Other Applications
8. Veterinary Molecular Diagnostics Market, by Animal Type
8.1. Introduction
8.2. Companion Animals
8.2.1. Dogs
8.2.2. Cats
8.2.3. Horses
8.2.4. Other Companion Animals
8.3. Livestock Animals
8.3.1. Cattle
8.3.2. Swine
8.3.3. Poultry
8.3.4. Small Ruminants
8.3.5. Other Livestock Animals
9. Veterinary Molecular Diagnostics Market, by End User
9.1. Introduction
9.2. Veterinary Reference & Diagnostic Laboratories
9.3. Veterinary Hospitals & Clinics
9.4. Research Institutes
10. Veterinary Molecular Diagnostics Market, by Geography
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Netherlands
10.3.7. Poland
10.3.8. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. South Korea
10.4.5. Australia
10.4.6. Vietnam
10.4.7. Rest of Asia-Pacific
10.5. Latin America
10.5.1. Brazil
10.5.2. Mexico
10.5.3. Argentina
10.5.4. Rest of Latin America
10.6. Middle East & Africa
10.6.1. Saudi Arabia
10.6.2. South Africa
10.6.3. Rest of Middle East & Africa
11. Competitive Landscape
11.1. Overview
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Competitive Dashboard
11.4.1. Market Leaders
11.4.2. Market Differentiators
11.4.3. Vanguards
11.4.4. Emerging Players
11.5. Market Share/Rank Analysis, by Key Player, 2025
12. Company Profiles
(Business Overview, Financial Overview, Veterinary Molecular Diagnostics Portfolio, Product Portfolio, Strategic Developments, SWOT Analysis)
12.1. IDEXX Laboratories, Inc.
12.2. Antech Diagnostics, Inc. (Mars, Incorporated)
12.3. Zoetis Inc.
12.4. Thermo Fisher Scientific Inc.
12.5. QIAGEN N.V.
12.6. Bio-Rad Laboratories, Inc.
12.7. Neogen Corporation
12.8. Indical Bioscience GmbH
12.9. Innovative Diagnostics SAS
13. Appendix
13.1. Related Reports
13.2. Customization Options
LIST OF TABLES
Table 1. Global Veterinary Molecular Diagnostics Market Drivers: Impact Analysis (2026-2036)
Table 2. Global Veterinary Molecular Diagnostics Market Restraints: Impact Analysis (2026-2036)
Table 3. Global Veterinary Molecular Diagnostics Market Opportunities: Impact Analysis (2026-2036)
Table 4. Global Veterinary Molecular Diagnostics Market Challenges: Impact Analysis (2026-2036)
Table 5. Impact Analysis of Market Determinants: Veterinary Molecular Diagnostics Market
Table 6. Molecular vs. Immunoassay-Based Veterinary Diagnostics: Comparative Analysis
Table 7. Key Transboundary Animal Diseases: ASF, HPAI (Including H5N1 in Dairy Cattle), Bluetongue, and Foot-and-Mouth Disease
Table 8. Key Regulations and Standards for Veterinary Molecular Assays, by Country/Region (WOAH, USDA CVB, NAHLN, EU Animal Health Law)
Table 9. Comparison of Veterinary Molecular Technologies: Real-Time and Digital PCR, Multiplex Panels, Isothermal, Sequencing, and Microarrays
Table 10. Porter's Five Forces Analysis: Veterinary Molecular Diagnostics Market
Table 11. Average Cost per Test for Veterinary Molecular Assays, by Technology
Table 12. Global Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 13. Global Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 14. Veterinary Molecular Diagnostics Market for Kits & Reagents, by Country/Region, 2024-2036 (USD Million)
Table 15. Veterinary Molecular Diagnostics Market for PCR Assay Kits, by Country/Region, 2024-2036 (USD Million)
Table 16. Veterinary Molecular Diagnostics Market for Nucleic Acid Extraction Kits, by Country/Region, 2024-2036 (USD Million)
Table 17. Veterinary Molecular Diagnostics Market for Sequencing Kits & Reagents, by Country/Region, 2024-2036 (USD Million)
Table 18. Veterinary Molecular Diagnostics Market for Other Reagents, by Country/Region, 2024-2036 (USD Million)
Table 19. Global Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 20. Veterinary Molecular Diagnostics Market for Instruments, by Country/Region, 2024-2036 (USD Million)
Table 21. Veterinary Molecular Diagnostics Market for PCR Systems, by Country/Region, 2024-2036 (USD Million)
Table 22. Veterinary Molecular Diagnostics Market for Sequencing Systems, by Country/Region, 2024-2036 (USD Million)
Table 23. Veterinary Molecular Diagnostics Market for Nucleic Acid Extraction Systems, by Country/Region, 2024-2036 (USD Million)
Table 24. Veterinary Molecular Diagnostics Market for Point-of-Care Molecular Analyzers, by Country/Region, 2024-2036 (USD Million)
Table 25. Veterinary Molecular Diagnostics Market for Software, by Country/Region, 2024-2036 (USD Million)
Table 26. Global Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 27. Global Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 28. Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Country/Region, 2024-2036 (USD Million)
Table 29. Veterinary Molecular Diagnostics Market for Real-Time PCR, by Country/Region, 2024-2036 (USD Million)
Table 30. Veterinary Molecular Diagnostics Market for Digital PCR, by Country/Region, 2024-2036 (USD Million)
Table 31. Veterinary Molecular Diagnostics Market for Conventional PCR, by Country/Region, 2024-2036 (USD Million)
Table 32. Global Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 33. Veterinary Molecular Diagnostics Market for DNA Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 34. Veterinary Molecular Diagnostics Market for Next-Generation Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 35. Veterinary Molecular Diagnostics Market for Sanger Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 36. Veterinary Molecular Diagnostics Market for Microarray, by Country/Region, 2024-2036 (USD Million)
Table 37. Veterinary Molecular Diagnostics Market for Other Technologies, by Country/Region, 2024-2036 (USD Million)
Table 38. Global Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 39. Global Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 40. Veterinary Molecular Diagnostics Market for Infectious Diseases, by Country/Region, 2024-2036 (USD Million)
Table 41. Veterinary Molecular Diagnostics Market for Viral Diseases, by Country/Region, 2024-2036 (USD Million)
Table 42. Veterinary Molecular Diagnostics Market for Bacterial Diseases, by Country/Region, 2024-2036 (USD Million)
Table 43. Veterinary Molecular Diagnostics Market for Parasitic Diseases, by Country/Region, 2024-2036 (USD Million)
Table 44. Veterinary Molecular Diagnostics Market for Fungal Diseases, by Country/Region, 2024-2036 (USD Million)
Table 45. Global Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 46. Veterinary Molecular Diagnostics Market for Genetics, by Country/Region, 2024-2036 (USD Million)
Table 47. Veterinary Molecular Diagnostics Market for Genetic Disease Testing, by Country/Region, 2024-2036 (USD Million)
Table 48. Veterinary Molecular Diagnostics Market for Genomic Selection & Trait Testing, by Country/Region, 2024-2036 (USD Million)
Table 49. Veterinary Molecular Diagnostics Market for Parentage & Identity Testing, by Country/Region, 2024-2036 (USD Million)
Table 50. Veterinary Molecular Diagnostics Market for Metabolic Diseases, by Country/Region, 2024-2036 (USD Million)
Table 51. Veterinary Molecular Diagnostics Market for Other Applications, by Country/Region, 2024-2036 (USD Million)
Table 52. Global Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 53. Global Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 54. Veterinary Molecular Diagnostics Market for Companion Animals, by Country/Region, 2024-2036 (USD Million)
Table 55. Veterinary Molecular Diagnostics Market for Dogs, by Country/Region, 2024-2036 (USD Million)
Table 56. Veterinary Molecular Diagnostics Market for Cats, by Country/Region, 2024-2036 (USD Million)
Table 57. Veterinary Molecular Diagnostics Market for Horses, by Country/Region, 2024-2036 (USD Million)
Table 58. Veterinary Molecular Diagnostics Market for Other Companion Animals, by Country/Region, 2024-2036 (USD Million)
Table 59. Global Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 60. Veterinary Molecular Diagnostics Market for Livestock Animals, by Country/Region, 2024-2036 (USD Million)
Table 61. Veterinary Molecular Diagnostics Market for Cattle, by Country/Region, 2024-2036 (USD Million)
Table 62. Veterinary Molecular Diagnostics Market for Swine, by Country/Region, 2024-2036 (USD Million)
Table 63. Veterinary Molecular Diagnostics Market for Poultry, by Country/Region, 2024-2036 (USD Million)
Table 64. Veterinary Molecular Diagnostics Market for Small Ruminants, by Country/Region, 2024-2036 (USD Million)
Table 65. Veterinary Molecular Diagnostics Market for Other Livestock Animals, by Country/Region, 2024-2036 (USD Million)
Table 66. Global Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 67. Veterinary Molecular Diagnostics Market for Veterinary Reference & Diagnostic Laboratories, by Country/Region, 2024-2036 (USD Million)
Table 68. Veterinary Molecular Diagnostics Market for Veterinary Hospitals & Clinics, by Country/Region, 2024-2036 (USD Million)
Table 69. Veterinary Molecular Diagnostics Market for Research Institutes, by Country/Region, 2024-2036 (USD Million)
Table 70. Global Veterinary Molecular Diagnostics Market, by Region, 2024-2036 (USD Million)
Table 71. Global Veterinary Molecular Diagnostics Market, by Country/Region, 2024-2036 (USD Million)
Table 72. North America: Veterinary Molecular Diagnostics Market, by Country, 2024-2036 (USD Million)
Table 73. North America: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 74. North America: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 75. North America: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 76. North America: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 77. North America: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 78. North America: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 79. North America: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 80. North America: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 81. North America: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 82. North America: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 83. North America: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 84. North America: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 85. North America: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 86. U.S.: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 87. U.S.: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 88. U.S.: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 89. U.S.: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 90. U.S.: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 91. U.S.: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 92. U.S.: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 93. U.S.: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 94. U.S.: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 95. U.S.: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 96. U.S.: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 97. U.S.: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 98. U.S.: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 99. Canada: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 100. Canada: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 101. Canada: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 102. Canada: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 103. Canada: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 104. Canada: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 105. Canada: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 106. Canada: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 107. Canada: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 108. Canada: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 109. Canada: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 110. Canada: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 111. Canada: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 112. Europe: Veterinary Molecular Diagnostics Market, by Country, 2024-2036 (USD Million)
Table 113. Europe: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 114. Europe: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 115. Europe: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 116. Europe: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 117. Europe: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 118. Europe: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 119. Europe: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 120. Europe: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 121. Europe: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 122. Europe: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 123. Europe: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 124. Europe: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 125. Europe: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 126. Germany: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 127. Germany: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 128. Germany: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 129. Germany: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 130. Germany: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 131. Germany: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 132. Germany: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 133. Germany: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 134. Germany: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 135. Germany: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 136. Germany: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 137. Germany: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 138. Germany: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 139. France: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 140. France: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 141. France: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 142. France: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 143. France: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 144. France: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 145. France: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 146. France: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 147. France: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 148. France: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 149. France: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 150. France: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 151. France: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 152. U.K.: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 153. U.K.: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 154. U.K.: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 155. U.K.: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 156. U.K.: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 157. U.K.: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 158. U.K.: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 159. U.K.: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 160. U.K.: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 161. U.K.: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 162. U.K.: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 163. U.K.: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 164. U.K.: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 165. Italy: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 166. Italy: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 167. Italy: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 168. Italy: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 169. Italy: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 170. Italy: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 171. Italy: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 172. Italy: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 173. Italy: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 174. Italy: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 175. Italy: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 176. Italy: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 177. Italy: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 178. Spain: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 179. Spain: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 180. Spain: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 181. Spain: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 182. Spain: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 183. Spain: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 184. Spain: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 185. Spain: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 186. Spain: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 187. Spain: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 188. Spain: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 189. Spain: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 190. Spain: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 191. Netherlands: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 192. Netherlands: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 193. Netherlands: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 194. Netherlands: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 195. Netherlands: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 196. Netherlands: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 197. Netherlands: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 198. Netherlands: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 199. Netherlands: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 200. Netherlands: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 201. Netherlands: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 202. Netherlands: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 203. Netherlands: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 204. Poland: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 205. Poland: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 206. Poland: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 207. Poland: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 208. Poland: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 209. Poland: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 210. Poland: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 211. Poland: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 212. Poland: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 213. Poland: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 214. Poland: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 215. Poland: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 216. Poland: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 217. Rest of Europe: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 218. Rest of Europe: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 219. Rest of Europe: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 220. Rest of Europe: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 221. Rest of Europe: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 222. Rest of Europe: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 223. Rest of Europe: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 224. Rest of Europe: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 225. Rest of Europe: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 226. Rest of Europe: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 227. Rest of Europe: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 228. Rest of Europe: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 229. Rest of Europe: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 230. Asia-Pacific: Veterinary Molecular Diagnostics Market, by Country, 2024-2036 (USD Million)
Table 231. Asia-Pacific: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 232. Asia-Pacific: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 233. Asia-Pacific: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 234. Asia-Pacific: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 235. Asia-Pacific: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 236. Asia-Pacific: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 237. Asia-Pacific: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 238. Asia-Pacific: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 239. Asia-Pacific: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 240. Asia-Pacific: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 241. Asia-Pacific: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 242. Asia-Pacific: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 243. Asia-Pacific: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 244. China: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 245. China: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 246. China: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 247. China: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 248. China: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 249. China: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 250. China: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 251. China: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 252. China: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 253. China: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 254. China: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 255. China: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 256. China: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 257. Japan: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 258. Japan: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 259. Japan: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 260. Japan: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 261. Japan: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 262. Japan: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 263. Japan: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 264. Japan: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 265. Japan: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 266. Japan: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 267. Japan: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 268. Japan: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 269. Japan: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 270. India: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 271. India: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 272. India: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 273. India: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 274. India: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 275. India: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 276. India: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 277. India: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 278. India: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 279. India: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 280. India: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 281. India: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 282. India: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 283. South Korea: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 284. South Korea: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 285. South Korea: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 286. South Korea: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 287. South Korea: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 288. South Korea: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 289. South Korea: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 290. South Korea: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 291. South Korea: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 292. South Korea: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 293. South Korea: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 294. South Korea: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 295. South Korea: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 296. Australia: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 297. Australia: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 298. Australia: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 299. Australia: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 300. Australia: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 301. Australia: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 302. Australia: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 303. Australia: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 304. Australia: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 305. Australia: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 306. Australia: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 307. Australia: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 308. Australia: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 309. Vietnam: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 310. Vietnam: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 311. Vietnam: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 312. Vietnam: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 313. Vietnam: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 314. Vietnam: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 315. Vietnam: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 316. Vietnam: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 317. Vietnam: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 318. Vietnam: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 319. Vietnam: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 320. Vietnam: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 321. Vietnam: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 322. Rest of Asia-Pacific: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 323. Rest of Asia-Pacific: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 324. Rest of Asia-Pacific: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 325. Rest of Asia-Pacific: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 326. Rest of Asia-Pacific: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 327. Rest of Asia-Pacific: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 328. Rest of Asia-Pacific: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 329. Rest of Asia-Pacific: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 330. Rest of Asia-Pacific: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 331. Rest of Asia-Pacific: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 332. Rest of Asia-Pacific: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 333. Rest of Asia-Pacific: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 334. Rest of Asia-Pacific: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 335. Latin America: Veterinary Molecular Diagnostics Market, by Country, 2024-2036 (USD Million)
Table 336. Latin America: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 337. Latin America: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 338. Latin America: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 339. Latin America: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 340. Latin America: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 341. Latin America: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 342. Latin America: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 343. Latin America: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 344. Latin America: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 345. Latin America: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 346. Latin America: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 347. Latin America: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 348. Latin America: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 349. Brazil: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 350. Brazil: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 351. Brazil: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 352. Brazil: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 353. Brazil: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 354. Brazil: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 355. Brazil: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 356. Brazil: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 357. Brazil: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 358. Brazil: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 359. Brazil: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 360. Brazil: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 361. Brazil: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 362. Mexico: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 363. Mexico: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 364. Mexico: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 365. Mexico: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 366. Mexico: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 367. Mexico: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 368. Mexico: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 369. Mexico: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 370. Mexico: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 371. Mexico: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 372. Mexico: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 373. Mexico: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 374. Mexico: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 375. Argentina: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 376. Argentina: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 377. Argentina: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 378. Argentina: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 379. Argentina: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 380. Argentina: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 381. Argentina: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 382. Argentina: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 383. Argentina: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 384. Argentina: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 385. Argentina: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 386. Argentina: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 387. Argentina: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 388. Rest of Latin America: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 389. Rest of Latin America: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 390. Rest of Latin America: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 391. Rest of Latin America: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 392. Rest of Latin America: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 393. Rest of Latin America: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 394. Rest of Latin America: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 395. Rest of Latin America: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 396. Rest of Latin America: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 397. Rest of Latin America: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 398. Rest of Latin America: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 399. Rest of Latin America: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 400. Rest of Latin America: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 401. Middle East & Africa: Veterinary Molecular Diagnostics Market, by Country, 2024-2036 (USD Million)
Table 402. Middle East & Africa: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 403. Middle East & Africa: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 404. Middle East & Africa: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 405. Middle East & Africa: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 406. Middle East & Africa: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 407. Middle East & Africa: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 408. Middle East & Africa: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 409. Middle East & Africa: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 410. Middle East & Africa: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 411. Middle East & Africa: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 412. Middle East & Africa: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 413. Middle East & Africa: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 414. Middle East & Africa: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 415. Saudi Arabia: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 416. Saudi Arabia: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 417. Saudi Arabia: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 418. Saudi Arabia: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 419. Saudi Arabia: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 420. Saudi Arabia: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 421. Saudi Arabia: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 422. Saudi Arabia: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 423. Saudi Arabia: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 424. Saudi Arabia: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 425. Saudi Arabia: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 426. Saudi Arabia: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 427. Saudi Arabia: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 428. South Africa: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 429. South Africa: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 430. South Africa: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 431. South Africa: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 432. South Africa: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 433. South Africa: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 434. South Africa: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 435. South Africa: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 436. South Africa: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 437. South Africa: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 438. South Africa: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 439. South Africa: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 440. South Africa: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 441. Rest of Middle East & Africa: Veterinary Molecular Diagnostics Market, by Product, 2024-2036 (USD Million)
Table 442. Rest of Middle East & Africa: Veterinary Molecular Diagnostics Market for Kits & Reagents, by Type, 2024-2036 (USD Million)
Table 443. Rest of Middle East & Africa: Veterinary Molecular Diagnostics Market for Instruments, by Type, 2024-2036 (USD Million)
Table 444. Rest of Middle East & Africa: Veterinary Molecular Diagnostics Market, by Technology, 2024-2036 (USD Million)
Table 445. Rest of Middle East & Africa: Veterinary Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Type, 2024-2036 (USD Million)
Table 446. Rest of Middle East & Africa: Veterinary Molecular Diagnostics Market for DNA Sequencing, by Type, 2024-2036 (USD Million)
Table 447. Rest of Middle East & Africa: Veterinary Molecular Diagnostics Market, by Application, 2024-2036 (USD Million)
Table 448. Rest of Middle East & Africa: Veterinary Molecular Diagnostics Market for Infectious Diseases, by Type, 2024-2036 (USD Million)
Table 449. Rest of Middle East & Africa: Veterinary Molecular Diagnostics Market for Genetics, by Type, 2024-2036 (USD Million)
Table 450. Rest of Middle East & Africa: Veterinary Molecular Diagnostics Market, by Animal Type, 2024-2036 (USD Million)
Table 451. Rest of Middle East & Africa: Veterinary Molecular Diagnostics Market for Companion Animals, by Type, 2024-2036 (USD Million)
Table 452. Rest of Middle East & Africa: Veterinary Molecular Diagnostics Market for Livestock Animals, by Type, 2024-2036 (USD Million)
Table 453. Rest of Middle East & Africa: Veterinary Molecular Diagnostics Market, by End User, 2024-2036 (USD Million)
Table 454. Veterinary Molecular Diagnostics Market: Key Growth Strategies Adopted by Leading Players (2024-2026)
Table 455. Veterinary Molecular Diagnostics Market: Strategic Developments, by Company (2024-2026)
Table 456. Veterinary Molecular Diagnostics Market: Competitive Benchmarking
Table 457. Veterinary Molecular Diagnostics Market: Market Share/Ranking Analysis, by Key Player (2025)
Table 458. IDEXX Laboratories, Inc.: Product Portfolio
Table 459. IDEXX Laboratories, Inc.: Strategic Developments
Table 460. Antech Diagnostics, Inc. (Mars, Incorporated): Product Portfolio
Table 461. Antech Diagnostics, Inc. (Mars, Incorporated): Strategic Developments
Table 462. Zoetis Inc.: Product Portfolio
Table 463. Zoetis Inc.: Strategic Developments
Table 464. Thermo Fisher Scientific Inc.: Product Portfolio
Table 465. Thermo Fisher Scientific Inc.: Strategic Developments
Table 466. QIAGEN N.V.: Product Portfolio
Table 467. QIAGEN N.V.: Strategic Developments
Table 468. Bio-Rad Laboratories, Inc.: Product Portfolio
Table 469. Bio-Rad Laboratories, Inc.: Strategic Developments
Table 470. Neogen Corporation: Product Portfolio
Table 471. Neogen Corporation: Strategic Developments
Table 472. Indical Bioscience GmbH: Product Portfolio
Table 473. Indical Bioscience GmbH: Strategic Developments
Table 474. Innovative Diagnostics SAS: Product Portfolio
Table 475. Innovative Diagnostics SAS: Strategic Developments
Table 476. Available Customization Options
Table 477. Available Related Reports
LIST OF FIGURES
Figure 1. Research Process
Figure 2. Key Secondary Sources
Figure 3. Primary Research Techniques
Figure 4. Key Executives Interviewed
Figure 5. Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6. Market Sizing and Growth Forecast Approach
Figure 7. Executive Summary: Global Veterinary Molecular Diagnostics Market Size, 2024-2036 (USD Million)
Figure 8. Executive Summary: Global Veterinary Molecular Diagnostics Market, by Product, 2026 vs. 2036 (USD Million)
Figure 9. Executive Summary: Global Veterinary Molecular Diagnostics Market, by Technology, 2026 vs. 2036 (USD Million)
Figure 10. Executive Summary: Global Veterinary Molecular Diagnostics Market, by Application, 2026 vs. 2036 (USD Million)
Figure 11. Executive Summary: Global Veterinary Molecular Diagnostics Market, by Animal Type, 2026 vs. 2036 (USD Million)
Figure 12. Executive Summary: Global Veterinary Molecular Diagnostics Market, by End User, 2026 vs. 2036 (USD Million)
Figure 13. Executive Summary: Global Veterinary Molecular Diagnostics Market, by Region, 2026 vs. 2036 (USD Million)
Figure 14. Executive Summary: Competitive Landscape of the Veterinary Molecular Diagnostics Market
Figure 15. Factors Impacting the Growth of the Veterinary Molecular Diagnostics Market
Figure 16. Value Chain Analysis: Veterinary Molecular Diagnostics Market
Figure 17. Animal Disease Landscape: Key Transboundary and Companion Animal Diseases
Figure 18. Veterinary Molecular Testing Workflow: Laboratory and Point-of-Care Testing
Figure 19. Porter's Five Forces Analysis: Veterinary Molecular Diagnostics Market
Figure 20. Global Veterinary Molecular Diagnostics Market, by Product, 2026 vs. 2036 (USD Million)
Figure 21. Global Veterinary Molecular Diagnostics Market, by Technology, 2026 vs. 2036 (USD Million)
Figure 22. Global Veterinary Molecular Diagnostics Market, by Application, 2026 vs. 2036 (USD Million)
Figure 23. Global Veterinary Molecular Diagnostics Market, by Animal Type, 2026 vs. 2036 (USD Million)
Figure 24. Global Veterinary Molecular Diagnostics Market, by End User, 2026 vs. 2036 (USD Million)
Figure 25. Global Veterinary Molecular Diagnostics Market, by Region, 2026 vs. 2036 (USD Million)
Figure 26. North America: Veterinary Molecular Diagnostics Market Snapshot
Figure 27. Europe: Veterinary Molecular Diagnostics Market Snapshot
Figure 28. Asia-Pacific: Veterinary Molecular Diagnostics Market Snapshot
Figure 29. Latin America: Veterinary Molecular Diagnostics Market Snapshot
Figure 30. Middle East & Africa: Veterinary Molecular Diagnostics Market Snapshot
Figure 31. Key Growth Strategies Adopted by Leading Players in the Veterinary Molecular Diagnostics Market (2024-2026)
Figure 32. Veterinary Molecular Diagnostics Market: Competitive Dashboard
Figure 33. Veterinary Molecular Diagnostics Market Share/Ranking Analysis, by Key Player (2025)
Figure 34. IDEXX Laboratories, Inc.: SWOT Analysis
Figure 35. Antech Diagnostics, Inc. (Mars, Incorporated): SWOT Analysis
Figure 36. Zoetis Inc.: SWOT Analysis
Figure 37. Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 38. QIAGEN N.V.: SWOT Analysis
Figure 39. Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 40. Neogen Corporation: SWOT Analysis
Figure 41. Indical Bioscience GmbH: SWOT Analysis
Figure 42. Innovative Diagnostics SAS: SWOT Analysis

Companies Mentioned

  • IDEXX Laboratories, Inc.
  • Antech Diagnostics, Inc.
  • Zoetis Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.
  • Neogen Corporation
  • Indical Bioscience GmbH
  • Innovative Diagnostics SAS